night willow-herb

Reported Uses

• NOTE: see Herb & Supplement Effectiveness Rating Definitions table
• acne [Insufficient Evidence]
• ADHD [Insufficient Evidence]
• Alzheimer dz [Insufficient Evidence]
• asthma [Possibly Ineffective]
• atopic dermatitis (eczema) [Insufficient Evidence]
• biliary disorders [Insufficient Evidence]
• chronic fatigue syndrome [Insufficient Evidence]
• coronary heart dz [Insufficient Evidence]
• developmental coordination disorder [Insufficient Evidence]
• diabetic neuropathy [Insufficient Evidence]
• dry eye dz [Insufficient Evidence]
• dry skin [Insufficient Evidence]
• dyslexia [Insufficient Evidence]
• endometriosis [Insufficient Evidence]
• gestational diabetes [Insufficient Evidence]
• hepatitis B [Insufficient Evidence]
• hyperlipidemia [Insufficient Evidence]
• hysteroscopy [Insufficient Evidence]
• IBS [Insufficient Evidence]
• ichthyosis vulgaris [Insufficient Evidence]
• infant development [Insufficient Evidence]
• intermittent claudication [Insufficient Evidence]
• liver CA [Insufficient Evidence]
• mastalgia [Likely Ineffective]
• menopausal sx [Insufficient Evidence]
• molluscum contagiosum [Insufficient Evidence]
• multiple sclerosis [Insufficient Evidence]
• obesity [Insufficient Evidence]
• osteopenia [Insufficient Evidence]
• osteoporosis [Insufficient Evidence]
• parturition [Insufficient Evidence]
• peptic ulcer [Insufficient Evidence]
• plaque psoriasis [Insufficient Evidence]
• polycystic ovary syndrome [Insufficient Evidence]
• postop pain [Insufficient Evidence]
• pre-eclampsia [Insufficient Evidence]
• premenstrual syndrome [Insufficient Evidence]
• psoriatic arthritis [Insufficient Evidence]
• Raynaud phenomenon [Insufficient Evidence]
• rheumatoid arthritis [Insufficient Evidence]
• schizophrenia [Insufficient Evidence]
• Sjogren syndrome [Insufficient Evidence]
• tardive dyskinesia [Insufficient Evidence]
• ulcerative colitis [Insufficient Evidence]